Chimeric Therapeutics Ltd is an Australian clinical-stage cell therapy company focused on developing and commercialising a range of cell therapies in oncology. The group's products under development ...
Chimeric Therapeutics Limited (ASX: CHM), a company focused on developing cell therapies to treat cancer, has announced it has secured firm commitments to raise $8.4 million. The funding comprises a ...
Placement and Convertible Note to Fully Fund Phase 1 Trial and Support Strategic Review Chimeric Therapeutics Limited (ASX: CHM), a company focused on developing cell therapies to treat cancer, has ...
AI-discovered candidate CHM-029 demonstrates robust, dose-dependent tumor regression in pre-clinical AML models and retains potency against all known resistance mutations First-in-human trials ...
LONDON – 13 November 2025 -- CHARM Therapeutics (“CHARM”, “The Company”), today announced the advancement of CHM-029, a next-generation pan-menin inhibitor designed to overcome resistance mutations, ...
This course provides a non-laboratory based introduction to basic concepts of chemistry. Topics include measurements, matter, energy, atomic theory, bonding, molecular structure, nomenclature, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results